Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Annals of Surgical Oncology|February 9, 2011
Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancerValentina Guarneri, Annarita Pecchi, Federico Piacentini, et al.
Oncotarget|September 1, 2018
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applicationsAngela Toss, Federico Piacentini, Laura Cortesi, et al.
Journal of Cancer Research and Clinical Oncology|January 4, 2019
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor statusClaudia Omarini, Stefania Bettelli, Cecilia Caprera, et al.
Cancer Management and Research|February 4, 2020
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant ChemotherapyClaudia Omarini, Patrizia Palumbo, Annarita Pecchi, et al.
Biomed Research International|August 25, 2018
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus EverolimusClaudia Omarini, Maria Elisabetta Filieri, Stefania Bettelli, et al.
Pathology, Research and Practice|January 3, 2025
Automate the process of formalin-fixed paraffin-embedded blocks storage in the pathology laboratory: A proof of concept studyAlbino Eccher, Stefano Marletta, Fabio Pagni, et al.
NPJ Breast Cancer|February 13, 2021
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancerGaia Griguolo, Maria Vittoria Dieci, Laia Paré, et al.
Frontiers in Digital Health|April 27, 2026
Preparing real-world data through common data model harmonization of cancer patient records in the COMNet platform at the Modena Oncology CenterLuca Moscetti, Enrico Calanchi, Elisa Pettorelli, et al.
International Journal of Molecular Sciences|March 13, 2024
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer PatientsFabio Canino, Antonio Tornincasa, Stefania Bettelli, et al.
Frontiers in Oncology|December 19, 2022
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapyAngela Toss, Marta Venturelli, Monica Civallero, et al.
Pageof 8